secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2026-04-02T23:59:59+00:00
Accession:  0001213900-26-039352
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma acquires QwikAgents software and domains for 2.1M shares
--------------------------------------------------------------------

- Asset purchase agreement with Many Ads Inc. for QwikAgents web application and domain names (qwikagents.com, .ai, .co).
- Consideration: 2,100,000 unregistered shares of Silo Pharma common stock, issued under Section 4(a)(2) exemption.
- Agreement includes customary representations, warranties, and indemnification provisions; liability capped at Purchase Price.
- Software includes Next.js/React portal and MCP server; open-source components disclosed (LGPL dependency noted).
- Transaction closed on March 30, 2026; domain transfer pending registrar processing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026039352/0001213900-26-039352-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390026039352/ea0284319-8k_silo.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-039352

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer